SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63015 355 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Welcome to the troll-free, moderated message board, made up of primarily ex-IMMU shareholders.
- IMMU's status:
--It is now a fully owned subsidiary of Gilead.

This board of ex IMMU shareholders who have gained the respect and trust of each other over many frustrating years of disappointment and heartache, yet having a thrilling ending, who still like to check in on what each other is thinking about other biotech investments. On the downside, the IMMU buyout was one of the last positive events in biotech before falling out of favor as a sector, and the efforts to turn some of the cash from the buyout into more growth has been a rough patch. However, most of us have gone through very rough and long periods of frustration and so most are experienced and seem to be mentally weathering this rough patch rather well.

Hopefully the combined knowledge and wisdom on this board will be financially beneficial over time in the biotech sector. I continue to monitor the board to keep it at the highest level that it has attained.

Etiquette:

This board is moderated, meaning the moderator (me) can stop people from posting here if they violate our norms. What are "our norms"? Well, be adult, play nice about sums it up. There are three responses I encourage for keeping the discussion civil and useful when you encounter a post that annoys you. In order of preference:

1> report a ToU violation to the SI admins via the link at the bottom of each post, they're good at dealing with problems.

2> send the person who posted a private message and work it out. Privately.

3> send me a private message. Wait a couple of days before doing so please, I'll usually see the message in that time frame and act (or not).

4> stay focused and leave politics out of it, even by inference. There are numerous forums you can spend as much time expounding on your favorite "why (insert favorite hot-button) is evil", we don't need to reiterate all that here.

5> do not engage in discussions about poster's motivations, etc. First of all, it's unprovable. Second I'd rather not wade through the inevitable pointless back-and-forth over something that'll never be settled anyway.

This board provides a forum for honest, civilized and friendly conversation. It is not a vehicle for spam or hidden agendas. New posters are not only welcome but are an important way to bring additional information and insights to the board. Over the years new posters have been welcomed into the group and have helped make the board successful. However, if you’re a new poster it is especially important to be sure that material assertions, be they pro or con, are thoughtful and supportable. While all posters must abide by the TOU, leeway can and will be granted to long-time posters who have made substantive contributions to the board and whose credibility has been established.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63015oqory.com ceo explained the reason for merger with vinc. This is a high risk stoforgetme-last Saturday
63014vinc buy it after merger with quory? just had reverse split and will go out of bforgetme-last Saturday
63013Over the last five years quarterly revenues have risen from 100 million to 700 mstockdoc772last Thursday
63012For those following SRPT: Not sure why, but saw this come across Fidelity news luckydog88-last Thursday
63011I looked at the JP Morgan Jan 2025 presentation. To me, this feels very similar jhcimmu-last Thursday
63010[graphic]forgetme2last Wednesday
63009It’s been said here several times that we were lucky to get the price we did frojargonweary9last Wednesday
63008Gilead posts strong earnings yesterday and increased its dividend. Among the kejargonweary7last Wednesday
63007immu lawsuit Did anyone here get any compensation from immunomedics lawsuit frforgetme-February 1
63006AVXL anavex.comsysiphus1January 27
63005SRPT release results from part 2 of EMBARK study.... Sarepta Therapeutics Annouerickerickson2January 27
63004AADI: Special Meeting: These proposals do not fill me with warm fuzzy feelingserickerickson-January 22
63003CTMX has been discussed on the board, just search "this subject" for terickerickson1January 19
63002[graphic]forgetme-January 18
63001I m not a newcomer. I was an immunomedics and immunogen investor until those tforgetme-January 18
63000Good afternoon! I trust the New Years is starting off well for all. Any thoughtsCFL Invest 1-January 15
62999Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Pherippetoe2January 15
62998Let's just say that the last couple of weeks have not been...kind...to my inerickerickson-January 15
62997Just an observation: Biogen market cap today just bottomed at $20+ bill or roughscorman11January 14
62996Got a message asking what my three biggest biotech holdings are. They are SRPT stockdoc773January 14
62995Don't know for sure but I think all the SAVA bulls have basically exited socstockdoc7710January 13
62994Joe Springer on SAVA. I got out of the stock before the implosion, but am just cFitzhughlaw-January 13
62993I assumed the name was coincidental and you posted that to amuse us, but in the erickerickson3January 13
62992David Goldenberg, having retired from research, is now writing spy novels. davili3511-January 13
62991Here is a list of some of the compounds/applications of Origin's CMF: origghettogoulash1January 9
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):